Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2002The Journal of Clinical Pharmacology

Pharmacokinetic and Safety Assessments of Galantamine and Risperidone after the Two Drugs Are Administered Alone and Together

View Full Paper
Ask AI
Bookmark
Share

Authors

FHFenglei HuangBeijing Institute of TechnologyKLKenneth C. LasseterAtrium Health Wake Forest BaptistLJLuc JanssensImelda Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huang et al. (2002) studied this question.

synapsesocial.com/papers/6a9f77bb3237489925f3ccb4https://doi.org/10.1177/0091270002042012005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia1999 · 748 citations
  2. 2A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors1995 · 105 citations
  3. 3Interventions for the Behavioral Complications of Alzheimer’s Disease:Behavioral Approaches1996 · 61 citations
  4. 4Psychiatric Complications of Dementia: Impact on Caregivers1997 · 63 citations
  5. 5A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia1999 · 620 citations